Group 1: Financial Performance - In 2024, the company achieved operating revenue of ¥391,719,678.83, a year-on-year increase of 28.14% [4] - The net profit attributable to shareholders was ¥25,815,418.23, a decrease of 2.75% year-on-year [4] - The net profit after deducting non-recurring gains and losses was ¥22,569,320.84, an increase of 6.74% year-on-year [4] - In Q1 2025, the company reported operating revenue of ¥9,519.57, a year-on-year growth of 26.68% [6] - The net profit attributable to shareholders in Q1 2025 was ¥464.50, a year-on-year increase of 29.80% [6] - The net profit after deducting non-recurring gains and losses in Q1 2025 was ¥328.55, a year-on-year increase of 37.15% [6] Group 2: Strategic Initiatives and Innovations - The company maintained a focus on "solidifying development quality" and achieved high-quality growth through the "one core, dual engines" strategy [5] - R&D investment increased by 31.39% in 2024, resulting in 5 new invention patents and 8 utility model patents [5] - The weighted average return on net assets after deducting non-recurring gains and losses increased by 0.16 percentage points year-on-year [5] - Accounts receivable turnover improved from 5.19 in 2023 to 5.69 in 2024, and inventory turnover improved from 2.30 in 2023 to 3.44 in 2024 [5] Group 3: Market Expansion and Product Development - Domestic sales revenue reached ¥48,423,500, a year-on-year increase of 58.58%, with a gross margin of 11.05%, up by 2.39 percentage points [5] - International sales revenue was ¥343,296,200, a year-on-year increase of 24.76% [5] - The company is actively participating in supplier bidding for mainstream optical module manufacturers, focusing on HDI PCB products [7] - The AI glasses-related FPC products began mass shipments in Q4 2024, contributing to sales growth in Q1 2025 [8] - The company is enhancing its technical capabilities in high-end wearable devices, including AI glasses and medical-grade hearing aids [8]